Decoding DNA Damage Response (DDR) Efficacy in Tumour Models to Advance Translation into the Clinic
Time: 9:20 am
day: Conference Day Two
Details:
• Identifying current challenges associated with evaluating DDR-targeted therapies in preclinical tumour models
• Uncovering assays to assess the effects of polymerase theta in combination therapy
• Exploring strategies to improve the translational relevance of DDR studies
